While the morbidity associated with insulin/dextrose has been demonstrated previously, this QIP was able to demonstrate a ‘real-world’ reduction in iatrogenic hypoglycaemia secondary to insulin/dextrose, through simple interventions and the introduction of SZC. The gene discussed is INS; the disease is Hypoglycemia.